Skip to main content
. 2019 Dec 12;2019(12):CD008661. doi: 10.1002/14651858.CD008661.pub2
Adverse event/effect(s): 5. Specific ‐ movement disorder ‐ average score (SAS, endpoint, high = poor, skewed data)
Study Mean (Modafinil group) SD (Modafinil group) N (Modafinil Group) Mean (Placebo group) SD (Placebo group) N (Placebo group)
Lohr 2013 4.1 3.46 12 5.3 4.5 12
Sevy 2005 0.3 0.7 10 0.6 1.1 10
Shafti 2016 5.71 3.39 25 5.98 4.01 25